Key facts
- This page summarizes Tsai Chen Lung's Form 4 filing for CapsoVision, Inc (CV).
- 5 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 07 Jul 2025, 17:27.
Tsai Chen Lung - 03 Jul 2025 Form 4 Insider Report for CapsoVision, Inc (CV)
- Reporting relationship
- Director
- Issuer ticker
- CV
- Reported as of
- 03 Jul 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Jul 2025, 17:27:36 UTC
- Prior SEC filing
- 01 Jul 2025
- Next SEC filing
- 17 Sep 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tai Vivatvaraphol, Attorney-in-Fact for Chen Lung Tsai
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Tsai Chen Lung filed Form 4 for CapsoVision, Inc (CV) on 07 Jul 2025.
Change
- Previous filing in this sequence was filed on 01 Jul 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001307275
Primary reporting owner
Tsai Chen Lung
- Relationship
- Director
- Address
- C/O CAPSOVISION, INC., 18805 COX AVENUE, SUITE 250, SARATOGA
- Signature
- /s/ Tai Vivatvaraphol, Attorney-in-Fact for Chen Lung Tsai
- Signature date
- 07 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CV
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +91,432
- Change %
- +381%
- Price
- Shares after
- 115,456
- Date
- 03 Jul 2025
- Ownership
- By trust.
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CV
transaction
Derivative
Series B Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -71,429
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 03 Jul 2025
- Ownership
- By trust.
- Underlying class
- Common Stock
- Underlying amount
- 21,450
- Exercise price
- Footnotes
- F1, F2
CV
transaction
Derivative
Series D-1 Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -55,555
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 03 Jul 2025
- Ownership
- By trust.
- Underlying class
- Common Stock
- Underlying amount
- 16,683
- Exercise price
- Footnotes
- F1, F2
CV
transaction
Derivative
Series E Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -86,956
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 03 Jul 2025
- Ownership
- By trust.
- Underlying class
- Common Stock
- Underlying amount
- 26,112
- Exercise price
- Footnotes
- F1, F2
CV
transaction
Derivative
Series H Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -90,534
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 03 Jul 2025
- Ownership
- By trust.
- Underlying class
- Common Stock
- Underlying amount
- 27,187
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each share of Series B preferred stock, Series D-1 preferred stock, Series E preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.
Footnote F2
The securities are held by The Tsai Family Trust, for which the Reporting Person, together with his wife, are trustees.